Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapyC. L. Creutzberg, A. Leon-Castillo,S. M. de Boer,M. E. Powell,L. R. Mileshkin,H. J. Mackay,A. Leary,H. W. Nijman,N. Singh,P. Pollock, A. Fyles,C. Haie-Meder,V. T. H. B. M. Smit,R. J. Edmondson,H. Putter,H. C. Kitchener,E. J. Crosbie,M. de Bruyn,R. Nout,T. BosseANNALS OF ONCOLOGY(2019)引用 24|浏览44暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要